CBG Oil 3000mg – Cannabigerol

Technical Specifications

  • Active Cannabinoid: Cannabigerol (CBG)
  • Total Potency: 3000 mg CBG
  • Bottle Volume: 50 ml (1.7 fl oz)
  • Concentration: 60 mg CBG per 1 ml
  • Extract Type: Full Spectrum
  • Extraction Method: Supercritical CO₂ extraction
  • THC Content: Trace amounts (< 0.3%), non-psychoactive
  • Carrier Oil: Medium Chain Triglycerides (MCT oil)
  • Additional Ingredients: Hemp Sativa L. Aerial Parts
  • Alcohol: Alcohol-free
  • Manufacturing: EU-based clean room, GMP-compliant facility
  • Delivery Format: Tincture (oral drops)
  • Packaging: Glass dropper bottle
  • Origin: Colorado, USA (hemp source)
  • Compliance: TGA-compliant for Australian regulations

$140.00

Description

Cannabigerol (CBG) oil represents a specialised segment within the broader hemp-derived cannabinoid category. Often referred to as the “mother cannabinoid,” CBG is a non-psychoactive compound that occurs naturally in hemp and cannabis plants. Unlike CBD or THC, CBG is present in smaller concentrations in mature plant material, making its extraction and isolation more resource-intensive. This product delivers 3000 mg of CBG in a 50 ml bottle, providing a concentration of 60 mg per millilitre. The formulation is designed for users seeking an alternative cannabinoid profile without the presence of detectable THC or psychoactive effects.

The extraction process relies on supercritical CO₂ technology, a method recognised for its ability to isolate cannabinoids without introducing residual solvents or alcohol. Supercritical CO₂ extraction operates under controlled temperature and pressure conditions, allowing selective separation of target compounds while preserving the integrity of the hemp plant’s natural cannabinoid and terpene profile. This process removes unwanted plant waxes, fats, and chlorophyll, resulting in a cleaner, more refined oil that integrates smoothly into daily routines.

This CBG oil is classified as full spectrum, meaning it retains a range of naturally occurring cannabinoids, terpenes, and flavonoids alongside the primary CBG content. Full spectrum formulations are often associated with the entourage effect—a hypothesis suggesting that cannabinoids and terpenes work synergistically to enhance overall bioavailability and interaction with the body’s endocannabinoid system. While CBG is the dominant cannabinoid in this product, trace amounts of CBD, CBC, and other minor cannabinoids may be present depending on the batch. The THC content remains below 0.3%, aligning with industrial hemp regulatory standards in Australia and most international jurisdictions.

Extraction and Manufacturing Standards

The carrier oil used in this formulation is MCT (medium-chain triglycerides) derived from coconut oil. MCT oil is chosen for its rapid absorption profile and neutral flavour, which makes sublingual administration more comfortable for users sensitive to the earthy taste of raw hemp extract. When taken sublingually, the oil is held under the tongue for 30 to 60 seconds before swallowing, allowing cannabinoids to bypass first-pass metabolism in the liver and enter the bloodstream more directly through the mucous membranes.

Manufacturing standards are another critical aspect of this product. Production takes place in an EU-based clean room facility that adheres to Good Manufacturing Practice (GMP) protocols. Clean room environments minimise contamination risks by controlling airborne particulates, temperature, and humidity. GMP compliance ensures consistency in ingredient sourcing, production processes, and batch-to-batch quality. Each bottle is tested for cannabinoid content and screened for common contaminants such as heavy metals, pesticides, and residual solvents. Batch-specific Certificates of Analysis (COA) should be verified directly through the manufacturer’s platform to confirm cannabinoid potency and purity.

CBG interacts with the endocannabinoid system, which is present in all mammals. However, it is important to note that CBG oil is not marketed as a therapeutic agent and is not intended to diagnose, treat, cure, or prevent any disease. Users should not interpret cannabinoid content as a substitute for professional medical advice. This product is intended for adults aged 18 and over who are exploring cannabinoid supplementation. Always consult with a healthcare professional before use.

Dosage and Usage Guidelines

Dosage guidance for CBG oil varies depending on individual factors such as body weight, metabolism, and prior experience with cannabinoids. Many users begin with a low dose—such as 0.25 to 0.5 ml (15 to 30 mg CBG)—and adjust incrementally based on personal response. Consistency in timing and dosage helps maintain stable cannabinoid levels in the body. Users should consult with healthcare professionals before introducing CBG oil, particularly if they are taking prescription medications or have underlying health conditions.

Storage recommendations include keeping the bottle in a cool, dark location away from direct sunlight and heat sources. Glass dropper bottles are designed to protect the oil from light exposure, which can degrade cannabinoids over time. Once opened, the product should be used within six months to ensure optimal potency and freshness.

This 3000 mg CBG oil is positioned as a mid-range strength option suitable for users transitioning from lower-potency formulations or those seeking a more concentrated dose without moving to the highest available strengths. The full spectrum profile, combined with supercritical CO₂ extraction and EU-compliant manufacturing, provides a foundation of quality assurance and traceability for informed consumers navigating the expanding cannabinoid market.

Aurum Australis offers this premium CBG oil as part of a curated selection of cannabinoid products designed for Australian consumers seeking transparency, quality, and regulatory compliance. Explore the full range of full spectrum, broad spectrum, and isolate formulations to find the cannabinoid profile that aligns with your needs.

Frequently Asked Questions (FAQ)

What is the difference between CBG and CBD oil?

CBG (cannabigerol) and CBD (cannabidiol) are both non-psychoactive cannabinoids derived from hemp, but they interact with the endocannabinoid system differently. CBG is often called the “mother cannabinoid” because other cannabinoids, including CBD, are synthesised from CBG during the plant’s growth cycle. While both cannabinoids are non-intoxicating, CBG is present in much smaller concentrations in mature hemp plants, making it more resource-intensive to extract. Users often choose CBG for its unique cannabinoid profile, while CBD remains the most widely researched and available hemp-derived compound.

Is this CBG oil legal in Australia?

Yes, hemp-derived CBG oil with THC content below 0.3% is legal in Australia under the Therapeutic Goods Administration (TGA) framework, provided it is sourced from industrial hemp and complies with Schedule 4 (Prescription Only) or over-the-counter regulations where applicable. This product contains trace THC (< 0.3%) and is manufactured to meet international hemp standards. However, users should verify the latest TGA guidelines and consult with healthcare professionals regarding legal requirements for cannabinoid products in their specific region or state.

How should I store my CBG oil to maintain potency?

CBG oil should be stored in a cool, dark location away from direct sunlight, heat sources, and moisture. Exposure to light and heat can degrade cannabinoids over time, reducing potency and effectiveness. The glass dropper bottle is designed to protect the oil from light, but it should still be kept in a cupboard or drawer rather than on a countertop. Once opened, the product should be used within six months for optimal freshness. Refrigeration is not necessary but can extend shelf life in warmer climates.